{"id":489747,"date":"2020-06-11T18:30:01","date_gmt":"2020-06-11T18:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=489747"},"modified":"2020-06-11T18:30:01","modified_gmt":"2020-06-11T18:30:01","slug":"clinical-trial-supplies-market-worth-25-billion-by-2025-key-factors-driving-market-growth","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/clinical-trial-supplies-market-worth-25-billion-by-2025-key-factors-driving-market-growth_489747.html","title":{"rendered":"Clinical Trial Supplies Market Worth $2.5 Billion by 2025 | Key Factors Driving Market Growth"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1591873318.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Clinical Trial Supplies Market Worth $2.5 Billion by 2025 | Key Factors Driving Market Growth\" src=\"https:\/\/www.abnewswire.com\/uploads\/1591873318.jpeg\" alt=\"Clinical Trial Supplies Market Worth $2.5 Billion by 2025 | Key Factors Driving Market Growth\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>The prominent players operating in the global clinical trial supplies market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US)<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Clinical Trial Supplies Market Report Provides Crucial Industry Insights That Will Help Your Business Grow. Know The Key Industry Trends.<\/div>\n<p style=\"text-align: justify;\">According to the new market research report&nbsp;<strong>&#8220;<\/strong><strong>Clinical Trial Supplies Market&nbsp;by Products &amp; Services (Manufacturing, Packaging, Logistics, Distribution, Storage), Phases ( l, ll, lll, lV), Drug Type (Small Molecule, Biologics),Therapeutic Areas (Oncology, Blood Disorders) &#8211; Global Forecast to 2025&#8243;<\/strong>, published by MarketsandMarkets&trade;, the Clinical Trial Supplies Market&nbsp;is projected to reach&nbsp;<span class=\"xn-money\">USD 2.5 billion<\/span>&nbsp;by 2025 from&nbsp;<span class=\"xn-money\">USD 1.7 billion<\/span>&nbsp;in 2020, at a CAGR of 7.8%.<\/p>\n<p><strong>Download PDF Brochure:<\/strong><br \/><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=172240059&amp;utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=172240059<\/a><\/p>\n<p>The increasing R&amp;D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials &amp; harmonization of regulations are the key factors driving the growth of this market.<strong>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/pressrelease.icrowdnewswire.com\/assets\/source\/users\/1902\/clinical-trial-supplies-market1.jpg?1591872840367\" alt=\"clinical-trial-supplies-market1\" \/><\/p>\n<p><\/strong><strong>Logistics services segment to dominate the Clinical Trial Supplies Market in 2020<\/p>\n<p><\/strong>Based on service, the market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of this market in 2020, primarily due to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.<\/p>\n<p><em>Browse&nbsp;in-depth TOC on<\/em><strong>&nbsp;&#8220;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/clinical-trial-supplies-market-172240059.html\" rel=\"nofollow noopener\" target=\"_blank\">Clinical Trial Supplies Market<\/a><strong>&#8220;<\/p>\n<p><\/strong><strong>132 &ndash; Tables<br class=\"dnr\" \/><\/strong><strong>37 &ndash; Figures&nbsp;&nbsp;<br class=\"dnr\" \/><\/strong><strong>158 &ndash; Pages<\/p>\n<p><\/strong><strong>Phase III segment to register the highest growth in the market, by phase<\/p>\n<p><\/strong>Based on phase, the market is segmented into phase I, phase II, phase III, phase IV, and BA\/BE studies. The phase III segment is expected to account for the largest share of the market in 2020. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the fact that phase III trials are the most expensive, time-consuming, and difficult to design and run.<\/p>\n<p><strong>Request Sample Pages:<br \/><\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=172240059\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=172240059<\/a><\/p>\n<p><strong><span class=\"xn-location\">North America<\/span>&nbsp;is the largest regional market for clinical trial supplies<\/p>\n<p><\/strong>The Global Clinical Trial Supplies Market is segmented into&nbsp;<span class=\"xn-location\">North America<\/span>,&nbsp;<span class=\"xn-location\">Europe<\/span>, the&nbsp;<span class=\"xn-location\">Asia Pacific<\/span>, and the Rest of the World.&nbsp;<span class=\"xn-location\">North America<\/span>&nbsp;is the largest regional market for clinical trial supplies, followed by&nbsp;<span class=\"xn-location\">Europe<\/span>. The large share of the North American market can primarily be attributed to the presence of well-established CROs and the high and growing R&amp;D expenditure by pharmaceutical and biopharmaceutical companies in the region.<\/p>\n<p>The prominent players operating in the global Clinical Trial Supplies Market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&amp;M Movianto (US), KLIFO A\/S (<span class=\"xn-location\">Denmark<\/span>), and Thermo Fisher Scientific, Inc. (US).<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=clinical-trial-supplies-market-worth-25-billion-by-2025-key-factors-driving-market-growth\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/clinical-trial-supplies-market-172240059.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/clinical-trial-supplies-market-172240059.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/clinical-trial-supplies-market-172240059.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=clinical-trial-supplies-market-worth-25-billion-by-2025-key-factors-driving-market-growth\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The prominent players operating in the global clinical trial supplies market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US) Clinical Trial Supplies Market Report Provides Crucial Industry Insights That Will Help Your Business Grow. &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/clinical-trial-supplies-market-worth-25-billion-by-2025-key-factors-driving-market-growth_489747.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,417,406,416],"tags":[],"class_list":["post-489747","post","type-post","status-publish","format-standard","hentry","category-Business","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/489747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=489747"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/489747\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=489747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=489747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=489747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}